J. Sergi
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 3
- Cancer Treatment and Pharmacology 2
- Neutropenia and Cancer Infections 2
-
- Immunotherapy and Immune Responses 4
- Co-authors
- Ronald M. Bukowski (10 shared papers)G. Thomas Budd (7 shared papers)Robert P. Whitehead (1 shared paper)Bruce G. Redman (1 shared paper)E. David Crawford (1 shared paper)Phyllis J. Goodman (1 shared paper)L. Bauer (5 shared papers)James H. Finke (5 shared papers)
- Journals
- Cancer (1 paper)Journal of Clinical Oncology (1 paper)Investigational New Drugs (1 paper)JNCI Journal of the National Cancer Institute (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
J. Sergi
13 papers receiving 310 citations
Peers
Comparison fields: 5 of 46
- Oncology 219
- Immunology 163
- Pulmonary and Respiratory Medicine 78
- Pathology and Forensic Medicine 39
- Radiology, Nuclear Medicine and Imaging 47
Countries citing papers authored by J. Sergi
This map shows the geographic impact of J. Sergi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Sergi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Sergi more than expected).
Fields of papers citing papers by J. Sergi
This network shows the impact of papers produced by J. Sergi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Sergi. The network helps show where J. Sergi may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Sergi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma. | 1991 | 80 |
| 2 | 1990 | 76 | |
| 3 | Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects. | 1989 | 42 |
| 4 | 1992 | 32 | |
| 5 | 1993 | 23 | |
| 6 | 1992 | 15 | |
| 7 | Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effects. | 1990 | 13 |
| 8 | 1993 | 12 | |
| 9 | Phase Ia-Ib trial of an anti-GD3 monoclonal antibody in combination with interferon-alpha in patients with malignant melanoma. | 1990 | 9 |
| 10 | Phase I trial of natural human interferon beta in metastatic malignancy. | 1991 | 7 |
| 11 | 1989 | 7 | |
| 12 | 1991 | 5 | |
| 13 | 1991 | 3 |
About J. Sergi
J. Sergi is a scholar working on Oncology, Immunology, Molecular Biology, Surgery and Genetics, having authored 13 papers that have together received 324 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers), Cancer Treatment and Pharmacology (2 papers), Cancer therapeutics and mechanisms (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Neutropenia and Cancer Infections (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (219 citations), Immunology (163 citations), Pulmonary and Respiratory Medicine (78 citations), Pathology and Forensic Medicine (39 citations) and Radiology, Nuclear Medicine and Imaging (47 citations). J. Sergi has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Ronald M. Bukowski, G. Thomas Budd, Robert P. Whitehead, Bruce G. Redman, E. David Crawford, Phyllis J. Goodman, L. Bauer, James H. Finke, Barbara P. Barna and Patricia Rayman. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Investigational New Drugs, JNCI Journal of the National Cancer Institute and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.